Institutional Ownership
Horizon Therapeutics Pub L
CUSIP G46188101SHSQ1 2026
13D / 13G Filings
9
Schedule 13D/13G on record
Beneficial Filers
3
Distinct reporting persons
Largest Stake
9.4%
Max % of class reported
Institutional Holders
1
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
9 filings · latest Feb 9, 2023
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Feb 9, 2023 | Vanguard Group Inc | 13G/A | 9.4% | 21.24M | SEC |
| 2 | Feb 9, 2023 | Fmr LLC | 13G/A | 0.1% | — | SEC |
| 3 | Feb 10, 2022 | Vanguard Group Inc | 13G/A | 8.9% | 20.14M | SEC |
| 4 | Feb 9, 2022 | Fmr LLC | 13G/A | 7.0% | — | SEC |
| 5 | Feb 11, 2021 | Renaissance Technologies LLC | 13G/A | 3.1% | 6.80M | SEC |
| 6 | Feb 10, 2021 | Vanguard Group Inc | 13G/A | 9.0% | 19.92M | SEC |
| 7 | Feb 8, 2021 | Fmr LLC | 13G | 6.0% | — | SEC |
| 8 | Feb 12, 2020 | Vanguard Group Inc | 13G/A | 9.1% | 17.09M | SEC |
| 9 | Feb 12, 2020 | Renaissance Technologies LLC | 13G | 5.4% | 10.10M | SEC |
Top Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Huntington National Bank | 1 | $116 |